propofol has been researched along with Cardiomyopathies in 13 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propofol is increasingly used for the treatment of status epilepticus due to the ease of use and tolerability, even if safety data from randomized clinical trials are lacking." | 7.74 | Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. ( Harris, BT; Jobst, BC; Zarovnaya, EL, 2007) |
| "Propofol, a central-acting sedative agent, has been implicated in the development of rhabdomyolysis in children." | 7.70 | Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. ( Apple, FS; Crosson, JT; Johari, VP; Smith, SA; Stelow, EB, 2000) |
| "Concerned patients present with Leigh syndrome symptoms or a Leigh-like syndrome." | 5.72 | A Case of ECHS1 Deficiency with Severe Encephalopathy and Status Epilepticus after a Propofol Sedation: Case Report. ( Lutz, S; Paraschaki, G; Preusse, M, 2022) |
| "Cardiac sarcoidosis is characterized by a high incidence of complete atrioventricular block, ventricular arrhythmia, and cardiac dysfunction." | 5.36 | [Total intravenous anesthesia for a patient with cardiac sarcoidosis associated with left ventricular dysfunction using remifentanil and propofol]. ( Kawamoto, M; Kusunoki, S; Miyoshi, H, 2010) |
| "Propofol is increasingly used for the treatment of status epilepticus due to the ease of use and tolerability, even if safety data from randomized clinical trials are lacking." | 3.74 | Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. ( Harris, BT; Jobst, BC; Zarovnaya, EL, 2007) |
| "Propofol, a central-acting sedative agent, has been implicated in the development of rhabdomyolysis in children." | 3.70 | Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. ( Apple, FS; Crosson, JT; Johari, VP; Smith, SA; Stelow, EB, 2000) |
| "Isoflurane provides protection against myocardial damage in a clinically used dosage as documented by lower levels of troponin-T in patients undergoing OPCAB surgery." | 2.76 | Myocardial protection with isoflurane during off-pump coronary artery bypass grafting: a randomized trial. ( Dutta, D; Garg, M; Minhas, H; Tempe, DK; Tomar, A; Virmani, S, 2011) |
| "Concerned patients present with Leigh syndrome symptoms or a Leigh-like syndrome." | 1.72 | A Case of ECHS1 Deficiency with Severe Encephalopathy and Status Epilepticus after a Propofol Sedation: Case Report. ( Lutz, S; Paraschaki, G; Preusse, M, 2022) |
| "Cardiac sarcoidosis is characterized by a high incidence of complete atrioventricular block, ventricular arrhythmia, and cardiac dysfunction." | 1.36 | [Total intravenous anesthesia for a patient with cardiac sarcoidosis associated with left ventricular dysfunction using remifentanil and propofol]. ( Kawamoto, M; Kusunoki, S; Miyoshi, H, 2010) |
| " Therefore, we tested the dose-response direct cardiac effects of clinically available induction agents in an isolated septic rat heart model." | 1.35 | Cardiac effects of induction agents in the septic rat heart. ( Busse, H; Graf, BM; Lunz, D; Sinner, B; Zausig, YA; Zink, W, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Preusse, M | 1 |
| Paraschaki, G | 1 |
| Lutz, S | 1 |
| Guerrero-Orriach, JL | 1 |
| Carmona-Luque, MD | 1 |
| Gonzalez-Alvarez, L | 1 |
| Weng, Y | 1 |
| Yuan, S | 1 |
| Li, H | 1 |
| Yu, W | 1 |
| Zausig, YA | 1 |
| Busse, H | 1 |
| Lunz, D | 1 |
| Sinner, B | 1 |
| Zink, W | 1 |
| Graf, BM | 1 |
| Miyoshi, H | 1 |
| Kusunoki, S | 1 |
| Kawamoto, M | 1 |
| Tempe, DK | 1 |
| Dutta, D | 1 |
| Garg, M | 1 |
| Minhas, H | 1 |
| Tomar, A | 1 |
| Virmani, S | 1 |
| Barrington, MJ | 1 |
| Kluger, R | 1 |
| Watson, R | 1 |
| Scott, DA | 1 |
| Harris, KJ | 1 |
| Higuchi, H | 1 |
| Maeda, S | 1 |
| Miyawaki, T | 1 |
| Kohjitani, A | 1 |
| Mori, T | 1 |
| Ishida, R | 1 |
| Egusa, M | 1 |
| Shimada, M | 1 |
| Fernández Sánchez, LJ | 1 |
| Pérez González, R | 1 |
| Guasch Arévalo, E | 1 |
| Martín Reyes, R | 1 |
| Gilsanz Rodríguez, F | 1 |
| Zarovnaya, EL | 1 |
| Jobst, BC | 1 |
| Harris, BT | 1 |
| Pizon, AF | 1 |
| Lovecchio, F | 1 |
| Stelow, EB | 1 |
| Johari, VP | 1 |
| Smith, SA | 1 |
| Crosson, JT | 1 |
| Apple, FS | 1 |
| Akkerdaas, LC | 1 |
| Mioch, P | 1 |
| Sap, R | 1 |
| Hellebrekers, LJ | 1 |
1 review available for propofol and Cardiomyopathies
| Article | Year |
|---|---|
Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress.
Topics: Anesthetics, Inhalation; Cardiac Surgical Procedures; Cardiomyopathies; Cardiotonic Agents; Heart Fa | 2022 |
4 trials available for propofol and Cardiomyopathies
| Article | Year |
|---|---|
Comparison of Cardioprotective Effects of Propofol versus Sevoflurane in Pediatric Living Donor Liver Transplantation.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Biomarkers; Cardiomyopathies; Child; Creatine Kin | 2020 |
Myocardial protection with isoflurane during off-pump coronary artery bypass grafting: a randomized trial.
Topics: Adjuvants, Anesthesia; Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Cardiomyopathies; Co | 2011 |
Epidural anesthesia for coronary artery bypass surgery compared with general anesthesia alone does not reduce biochemical markers of myocardial damage.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Biomarkers; Cardiomyopath | 2005 |
Cardiopulmonary effects of three different anaesthesia protocols in cats.
Topics: Acepromazine; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia, General; Anesthe | 2001 |
8 other studies available for propofol and Cardiomyopathies
| Article | Year |
|---|---|
A Case of ECHS1 Deficiency with Severe Encephalopathy and Status Epilepticus after a Propofol Sedation: Case Report.
Topics: Atrophy; Cardiomyopathies; Enoyl-CoA Hydratase; Humans; Infant; Leigh Disease; Lipid Metabolism, Inb | 2022 |
Cardiac effects of induction agents in the septic rat heart.
Topics: Analgesics; Anesthetics, Intravenous; Animals; Cardiomyopathies; Dose-Response Relationship, Drug; G | 2009 |
[Total intravenous anesthesia for a patient with cardiac sarcoidosis associated with left ventricular dysfunction using remifentanil and propofol].
Topics: Aged, 80 and over; Anesthesia, Intravenous; Cardiomyopathies; Colectomy; Hepatectomy; Humans; Male; | 2010 |
Dental management of a patient with takotsubo cardiomyopathy: a case report.
Topics: Adult; Anesthesia, Dental; Anesthetics, Intravenous; Cardiomyopathies; Conscious Sedation; Dental Ca | 2007 |
[Perioperative treatment of a pregnant woman with recent cerebral infarction secondary to noncompaction cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Androstanols; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, | 2006 |
Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus.
Topics: Acidosis; Adult; Age Factors; Anticonvulsants; Cardiac Output, Low; Cardiomyopathies; Fatal Outcome; | 2007 |
Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: a case report.
Topics: Baclofen; Cardiomyopathies; Drug Therapy, Combination; Humans; Infusion Pumps, Implantable; Injectio | 2007 |
Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings.
Topics: Adult; Biomarkers; Cardiomyopathies; Creatine Kinase; Female; Humans; Hypnotics and Sedatives; Kidne | 2000 |